Abstract
Patients with opioid-induced constipation (OIC) frequently relate their constipation burden to uncomfortable passing of hard, dry stools. Although naloxegol (Movantik™) increases spontaneous bowel movement frequency, its effects on normalizing stool consistency have not been fully described. This post-hoc analysis of the KODIAC clinical trials describes naloxegol effects on stool consistency.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
